Asia | Pharma | Healthcare News

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

ipharmaservices

Jul 11

Biogen Announces Approval of Leqembi for Alzheimer’s Disease in Hong Kong | iPharmaCenter

Brazil and Thailand Introduce New Single-Dose Malaria Cure to Combat Plasmodium vivax | iPharmaCenter

ipharmaservices

Jul 8

Brazil and Thailand Introduce New Single-Dose Malaria Cure to Combat Plasmodium vivax | iPharmaCenter

CDSCO Drug Approvals | India | Pharma | Health | Drug Approvals | 2024 | iPharmaCenter

ipharmaservices

Feb 3

CDSCO Drug Approvals | India | Pharma | Health | Drug Approvals | 2024 | iPharmaCenter

South Korea Healthcare News - MoHW aims to support supply of essential medicines | iPharmaCenter

ipharmaservices

Nov 26, 2023

South Korea Healthcare News - MoHW aims to support supply of essential medicines | iPharmaCenter

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

ipharmaservices

Jan 3, 2022

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

China released the 2022 NDRL list, Chinese pharma benefited from the list

ipharmaservices

Dec 4, 2021

China released the 2022 NDRL list, Chinese pharma benefited from the list

WHO granted EUL to Covaxin; acclaims easy storage requirement

ipharmaservices

Nov 3, 2021

WHO granted EUL to Covaxin; acclaims easy storage requirement

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Bayer submitted vericiguat for market authorization in China

ipharmaservices

Aug 28, 2020

Bayer submitted vericiguat for market authorization in China

Bayer’s Xofigo received approval for prostate cancer in China

ipharmaservices

Aug 27, 2020

Bayer’s Xofigo received approval for prostate cancer in China

Merck’s Keytruda received one more indication and dosage form approval in Japan

ipharmaservices

Aug 25, 2020

Merck’s Keytruda received one more indication and dosage form approval in Japan

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

ipharmaservices

Aug 22, 2020

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

JAPAN HEALTHCARE SYSTEM

ipharmaservices

Aug 17, 2020

JAPAN HEALTHCARE SYSTEM

ipharmaservices

Aug 12, 2020

China’s National Medicinal Products Administration approved Gilead’s Truvada

ipharmaservices

Jul 9, 2020

Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

ipharmaservices

Jun 23, 2020

Merck’s Keytruda approved in China for esophageal squamous cell carcinoma

ipharmaservices

Jun 23, 2020

GSK and Clover Biopharmaceuticals begins COVID-19 vaccine Phase 1 clinical trial

May witnessed the approval of Pfizer’s Talzenna, Nyprax’s Tukysa, Drug Houses’ Ajovy in Singapore

ipharmaservices

Jun 4, 2020

May witnessed the approval of Pfizer’s Talzenna, Nyprax’s Tukysa, Drug Houses’ Ajovy in Singapore

ipharmaservices

Jun 3, 2020

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page